“True stability requires comprehensive federal legislation that creates a national medical cannabis framework to recognize cannabis-based therapies as part of modern healthcare.”
By Steph Sherer, Americans for Safe Access
Last week, the House Appropriations Committee declared victory, announcing:
“More than 95 percent of the federal government is funded through full-year FY2026 appropriations—delivering stability, certainty, and results for the American people.”
But for millions of medical cannabis patients, that claim rings hollow.
Instead of delivering stability, the Fiscal Year 2026 budget reinforces a troubling reality: Congress continues to manage medical cannabis through temporary fixes and political compromises—rather than building a healthcare system patients can rely on.
Widespread misinformation about the true impact of President Donald Trump’s December 2025 executive order is compounding uncertainty for patients. While the order does emphasize research and coordination, it does not resolve core access barriers, create new patient protections or replace the need for congressional action. So, while a significant development, it is not necessarily the breakthrough it has been portrayed as.
As a result, uncertainty is growing across the patient community. Those who rely on hemp-derived medicines, veterans dependent on Department of Veterans Affairs (VA) healthcare and people living in newly authorized or underdeveloped state
Read full article on Marijuana Moment
